Phivida Holdings Inc. (“Phivida” or the “Company“) (CSE:VIDA) is pleased to report a partnership with Superheroes Management (SHM) sports marketing agency; and the signing of World Surfing League gold medalist, Ms. Malia Manuel as Phivida’s Lead Brand Ambassador.

Mr. Jaimeson Keegan is the founder of SHM and is the former Director of Sports and Culture Marketing at Redbull. Mr. Keegan built a global roster of world-class athletes, musicians, celebrities at Redbull, managing the USACaribbean and Canada. Phivida is focused on building brand awareness within key markets across the Pacific coast. By adding SHM to the team, Phivida activates a sports endorsement initiative central to its global brand strategy.


As the inaugural SHM signing, Phivida is pleased to welcome Ms. Malia Manuel as the Lead Brand Ambassador. A native of Kauai Hawaii, and resident of Laguna California, Ms. Manuel is an active competitor on the World Surfing League circuit. In 2012 Malia Manuel became the youngest woman ever to win a gold medal in a World Surfing League Championship (WSJ) at the age of 14. Malia later became an icon within the southern California surfing culture. Other global lifestyle brands sponsoring Malia include; Lululemon, Jeep, O’Neil and Sanuk. Visit https://www.youtube.com/results?search_query=malia+manuel for coverage of Malia in past competition.

phivida-news-spotlight

Phivida CEO John Belfontaine states; “we are proud to welcome Malia to the Phivida Team as our Lead Brand Ambassador. Malia embodies the spirit of Phivida as evidenced through her dedication to her sport, her ideals, and to her community. Malia is a fierce competitor, but more importantly, she’s a positive role model for young people around the world who dare to dream the impossible. We’re not just her sponsors, we’re also her fans.”

Phivida seeks to equip, empower and educate professional athletes, and active professionals with the option of using CBD-Hemp oil extract as an alternative to opiate-based pain killers to; optimize daily performance, treat chronic pain and inflammation-based conditions and to recover from training, and sports related injuries.

On January 1st 2018 the World Anti-Doping Agencies (WADA) officially removed cannabidiol (CBD) from their prohibited substances list. Phivida’s Nano-CBD™ is a natural opiate replacement therapy now available to athletes around the world, for the first time in the history of competitive sports. WADA’s decision comes in contrast to a rising global opiate epidemic, and the increased use of pain killers within professional and amateur sport.

Superheroes Management

SHM specializes in cultivating, fulfilling and activating strategic sports partnerships with lifestyle brands by connecting brands with iconic figures and elevating brand awareness through social and broadcast media. Superheroes Management athletes have won forty-seven (47) X-Games medals since their inception. For more information on SHM visit http://superheroesmgmt.com.

Phivida Holdings Inc.

Phivida (“fii-VEE-daa”) is a premier brand of cannabidiol (“CBD”) infused functional foods, beverages and clinical products. Using nanoencapsulation technology, Phivida converts phytocannabinoids into water soluble delivery format, enhancing bioavailability, and timed released within the body. Phivida’s Nano-CBD™ is infused into functional beverages, foods and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health conditions, from chronic pain to terminal diseases. The World Anti-Doping Association’s recent decision to lift its ban of CBD from hemp oil and the World Health Organization’s recent statement supports the clinical benefits of CBD for athletes worldwide. For more information visit www.phivida.com or join our social media rel=”nofollow”>network @Phivida. For investor inquiries please contact us via the information listed below.

FORWARD-LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, the Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Click here to connect with Phivida Holdings Inc. (“Phivida” or the “Company“) (CSE:VIDA) and receive an Investors Presentation. 

Source: markets.businessinsider.com

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less